Final Program

MONDAY • MAY 16 179
P225 Direct Cost-of-Illness Study of Asthma in Quebec/L. Blais, C.
Lemiere, A. Forget, F.-Z. Kettani, T. Dang-Tan, S. Zhang, D.
Corriveau, A. Ismaila, Montreal, Canada, p.A3716
P226
P227
P228
B49
Psychosocial, Quality of Life and Socioeconomic Outcomes of
Patients with Work-Related Asthma and Relationships to
Different Models of Clinic Organization/J.C. Lipszyc, F.
Silverman, D.L. Holness, G.M. Liss, K.L. Lavoie, S.M. Tarlo,
Toronto, Canada, p.A3717
The Effect of Co-Morbidities on Productivity Loss in Patients
with Asthma/S. Ehteshami-Afshar, J.M. FitzGerald, C. Carlsten, R.
Rousseau, W.C. Tan, J.D. Rolf, M. Sadatsafavi, Vancouver,
Canada, p.A3718
Asthma Triggered by Wildfires Can Be Measured Via
Smartphone App: The Asthma Mobile Health Study/I. Gowda,
N. Genes, N. Tignor, P. Wang, Y.-F.Y. Chan, S. Hershman, M.
Zweig, S. Violante, E. Schadt, L. Rogers, C.A. Powell, New York,
NY, p.A7825
THEMATIC POSTER SESSION
NON-TUBERCULOUS MYCOBACTERIAL DISEASE
AND CASE REPORTS
9:00 a.m. - 4:15 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area L, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitator:
P1219
P1220
P1221
P1222
P1223
T.K. Marras, MD, Toronto, Canada
Laboratory Based Survey for Pulmonary Non-Tuberculous
Mycobacteriosis in Japan: 2012-213/K. Morimoto, N. Hasegawa,
K. Izumi, H. Namkoong, K. Uchimura, Y. Hoshino, A. Kurashima, J.
Sokunaga, S. Shibuya, M. Shimojima, M. Ato, S. Mitarai, Tokyo,
Japan, p.A3719
Updated 4th Generation QuantiFERONr-TB Testing in
Individuals with Nontuberculous Mycobacteria Infection/S.A.
Siegel, M. Cavanaugh, J.H. Ku, A. Knights, L.M. Kawamura, K.L.
Winthrop, Portland, OR, p.A3720
Lung Function Decline Based on Clinical Course in Patients
with Non-Tuberculous Mycobacterial Lung Disease/H.Y. Park,
B.-H. Jeong, H.R. Chon, H. Lee, K. Jeon, W.-J. Koh, Seoul, Korea,
Republic of, p.A3721
12-Month Follow-Up Data from a Phase 2 Trial of Liposomal
Amikacin for Inhalation (LAI) in Patients with Refractory
Nontuberculous Mycobacterial (NTM) Lung Infection/K.N.
Olivier, D.E. Griffith, K.L. Winthrop, B.A. Brown-Elliott, G. Eagle, J.
McGinnis, R.J. Wallace, Bethesda, MD, p.A3722
Progression of Mycobacterium Avium Complex Infection to
Extensive Structural Disease and Hydropneumothorax in an
Otherwise Healthy Adult Male/C.J. VanHook, B. Warner, E.J.
McManus, Longmont, CO, p.A3723
P1224
P1225
P1226
P1227
P1228
P1229
P1230
P1231
Facilitator:
P1232
P1233
P1234
P1235
P1236
P1237
An Unusual Case of Mycobacterium Avium Complex/B.-C.
Tran, Baltimore, MD, p.A3724
Unusual Presentation of Mycobacterium Avium Complex Lung
Infection/V. Trivedi, T.R. Aksamit, L. Karnatovskaia, Rochester,
MN, p.A3725
In Sickness and In Health: Distinct Presentations of
Mycobacterium Avium Complex in a Married Couple/T.L.
Griffiths, S.L. Schmidt, Grand Rapids, MI, p.A3726
Mycobacterial Avium Complex Presenting with Fever and
Large Necrotizing Lung Mass in Immunocompetent HIV
Patient/F. Aldaas, A.A. Mitma, D.J. Rudolph, S. Zane, Bridgeport,
CT, p.A3727
TB, or Not TB: A Case of Concomitant Tuberbulosis Pleurisy
and Parenchymal Mycobacterium Avium Complex/E. Nadler, M.
Ordoveza, J. Ivanaviciene, Farmington, CT, p.A3728
An Endobronchial Mass in a Patient Post Bilateral Lung
Transplant/L.A. Cohen, W.R. Hunt, Atlanta, GA, p.A3729
Eosinophilic Pneumonia and Mycobacterial Infection/J.E.
Hines, A. Mohamed Hosni, Ypsilanti, MI, p.A3730
Nontuberculous Mycobacterial Hypersensitivity Pneumonitis
Secondary to Hot Tub Exposure/G.Y. Liu, N. Sirikonda, K.
Hussain, Morgantown, WV, p.A3731
J. Philley, MD, Tyler, TX
Airway Deposition and Retention of Liposomal Amikacin for
Inhalation in Patients with Pulmonary Nontuberculous
Mycobacterial Disease/K.N. Olivier, R. Maas-Moreno, M. Whatley,
K. Cheng, J.-H. Lee, C. Fiorentino, R. Shaffer, S. Macdonald, R.
Gupta, T.E. Corcoran, V.S. Malinin, G. Eagle, W. Perkins, C. Paik,
C. Chen, Bethesda, MD, p.A3732
CaMoMy Trial: A Prospective Randomized Clinical Trial to
Compare Six-Months Sputum Conversion Rate with a
Clarithromycin or Moxifloxacin Containing Regimen in Patients
with a M. Xenopi Pulmonary Infection: Intermediate
Analysis/C. Andrejak, N. Veziris, F.-X. Lescure, H. Mal, D. Bouvry,
L. Bassinet, F.-X. Blanc, J. Camuset, F. Couturaud, J.-F. Bervar,
C.-H. Marquette, L. Thiberville, H. Vallerand, J.-C. Dalphin, H.
Morel, J. Andrejak, J. Cadranel, V. Jounieaux, Amiens, France,
p.A3733
Liposome-Ciprofloxacin Inhibits Mycobacterium avium subs
hominissuis (MAH) Microaggregate Formation in a Dose and
Time Dependent Manner/L.E. Bermudez, J. Blanchard, L. Babrak,
I. Gonda, Corvallis, OR, p.A3734
Preliminary Evaluation of a Sitafloxacin - Containing Regimen
for Relapsed or Refractory Pulmonary Mycobacterium Avium
Complex Disease/K. Fujita, M. Fujita, Y. Ito, T. Hirai, T. Mio, K.
Watanabe, M. Mishima, Kyoto, Japan, p.A3735
Nontuberculous Mycobacteria Infection in a Case Diagnosed
with Ankylosing Spondylitis/N. Dirican, M. Pinar, S. Erturk, A.
Aynali, S. Atalay, M. Cakir, Isparta, Turkey, p.A3736
Mounier-Kuhn Syndrome Presenting with Dysphagia and
Weight Loss/D. Becnel, J.J. Barretto, P.S. Sriram, Gainesville, FL,
p.A3737
MONDAY MORNING
ATS 2016 • San Francisco